Trial Comparing Behavioral Activation to Relapse Prevention for Veterans with AUD and PTSD
This clinical trial aims to adapt and evaluate Behavioral Activation for veterans with co-occurring AUD and PTSD against Relapse Prevention.
Phase III
Mental Health / Behavioral Interventions
Status
Active
Signal Score
8.2
Signal assessment
Signal strength
high
Confidence level
moderate
Why it matters
This trial is significant as it explores innovative treatment options for veterans suffering from co-occurring AUD and PTSD, a demographic that often faces unique challenges in mental health care. The outcomes could reshape clinical practices and funding priorities in mental health interventions for this population.
Recommended action
Humanexa recommends Monitor: Monitoring is recommended to track the trial's outcomes and their implications for treatment strategies, as the results could inform future clinical practices and resource allocation.
Analysis
Monitor results on feasibility and acceptability of Behavioral Activation, as well as any significant outcomes related to AUD/PTSD recovery.
Related companies & assets
Sources & Humanexa intelligence
Source links
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.